| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 859 | 38.396 | 53.511 | 55.142 |
| Total Income - EUR | - | - | - | - | - | - | 936 | 39.557 | 53.942 | 55.147 |
| Total Expenses - EUR | - | - | - | - | - | - | 13.359 | 43.009 | 38.111 | 39.832 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -12.423 | -3.452 | 15.831 | 15.315 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -12.451 | -4.642 | 15.292 | 14.763 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Souplesse Clinique S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 31.862 | 53.449 | 50.352 | 42.068 |
| Current Assets | - | - | - | - | - | - | 8.397 | 16.609 | 22.214 | 7.171 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 17.638 | 692 |
| Receivables | - | - | - | - | - | - | 7.772 | 15.162 | 0 | 67 |
| Cash | - | - | - | - | - | - | 625 | 1.448 | 4.577 | 6.413 |
| Shareholders Funds | - | - | - | - | - | - | -12.411 | -17.092 | -4.134 | -4.380 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 52.670 | 87.150 | 78.406 | 53.672 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9623 - 9623" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Souplesse Clinique S.r.l.